These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23920307)

  • 1. Endoscopic-assisted 5-aminolevulinic acid imaging.
    Schwartz TH
    World Neurosurg; 2014; 82(1-2):e117-8. PubMed ID: 23920307
    [No Abstract]   [Full Text] [Related]  

  • 2. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.
    Rapp M; Kamp M; Steiger HJ; Sabel M
    World Neurosurg; 2014; 82(1-2):e277-9. PubMed ID: 23871813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
    Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
    World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 2: theoretical, biochemical and practical aspects.
    Colditz MJ; Leyen Kv; Jeffree RL
    J Clin Neurosci; 2012 Dec; 19(12):1611-6. PubMed ID: 23059058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [5-ALA fluorescence guided tumor resection].
    Yamaguchi F; Teramoto A; Takahashi H
    No To Shinkei; 2006 Dec; 58(12):1027-33. PubMed ID: 17193952
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results.
    Tykocki T; Michalik R; Bonicki W; Nauman P
    Neurol Neurochir Pol; 2012; 46(1):47-51. PubMed ID: 22426762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.
    Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U;
    J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies.
    Colditz MJ; Jeffree RL
    J Clin Neurosci; 2012 Nov; 19(11):1471-4. PubMed ID: 22959448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminolevulinic acid fluorescence guided resection of malignant glioma: Hong Kong experience.
    Chan DTM; Yi-Pin Sonia H; Poon WS
    Asian J Surg; 2018 Sep; 41(5):467-472. PubMed ID: 28844780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant gliomas--a new treatment modality].
    Cortnum S; Laursen R
    Ugeskr Laeger; 2013 Feb; 175(9):570-3. PubMed ID: 23608006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.
    Roberts DW; Valdés PA; Harris BT; Fontaine KM; Hartov A; Fan X; Ji S; Lollis SS; Pogue BW; Leblond F; Tosteson TD; Wilson BC; Paulsen KD
    J Neurosurg; 2011 Mar; 114(3):595-603. PubMed ID: 20380535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluorescence-guided resection with 5-aminolevulinic acid of an intramedullary tumor].
    Bernal-García LM; Cabezudo-Artero JM; Ortega-Martínez M; Fernández-Portales I; Giménez-Pando J; Ugarriza-Echebarrieta LF; Mata-Gómez J; Molina-Orozco M; Malca-Balcázar JF
    Neurocirugia (Astur); 2010 Aug; 21(4):312-6. PubMed ID: 20725700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Aminolevulinic Acid: Pitfalls of Fluorescence-guided Resection for Malignant Gliomas and Application for Malignant Glioma Therapy.
    Yamamoto J; Kitagawa T; Miyaoka R; Suzuki K; Takamatsu S; Saito T; Nakano Y
    J UOEH; 2020; 42(1):27-34. PubMed ID: 32213740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas.
    Hou C; Yamaguchi S; Ishi Y; Terasaka S; Kobayashi H; Motegi H; Hatanaka KC; Houkin K
    J Neurooncol; 2019 Jun; 143(2):197-206. PubMed ID: 30929128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study).
    Díez Valle R; Slof J; Galván J; Arza C; Romariz C; Vidal C;
    Neurologia; 2014 Apr; 29(3):131-8. PubMed ID: 23870657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To what extent will 5-aminolevulinic acid change the face of malignant glioma surgery?
    Díez Valle R; Tejada Solis S
    CNS Oncol; 2015; 4(4):265-72. PubMed ID: 26118538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validating a new generation filter system for visualizing 5-ALA-induced PpIX fluorescence in malignant glioma surgery: a proof of principle study.
    Suero Molina E; Stögbauer L; Jeibmann A; Warneke N; Stummer W
    Acta Neurochir (Wien); 2020 Apr; 162(4):785-793. PubMed ID: 32034493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.
    Hickmann AK; Nadji-Ohl M; Hopf NJ
    J Neurooncol; 2015 Mar; 122(1):151-60. PubMed ID: 25557106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in Gliomas.
    Ma R; Watts C
    Acta Neurochir (Wien); 2016 Oct; 158(10):1935-41. PubMed ID: 27496021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence and image guided resection in high grade glioma.
    Panciani PP; Fontanella M; Schatlo B; Garbossa D; Agnoletti A; Ducati A; Lanotte M
    Clin Neurol Neurosurg; 2012 Jan; 114(1):37-41. PubMed ID: 21963142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.